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Introduction {#sec1}
============

Even early in development, the heart siphons primordial blood while continuing its journey through the difficult rearrangements and growth needed for it to become a fully configured organ ([@bib36]). During this complex process, missteps occur frequently (1%--2% of newborns have congenital heart defects; [@bib14]) and the adult heart shows little regeneration ([@bib36]). Molecularly, cardiogenesis entails coordinated efforts among diverse transcription factors ([@bib31]). Some of these factors, such as Nkx2.5, assign cell identity early and broadly ([@bib24]); others, such as Tbx5, act later and in more bound cellular neighborhoods within the cardiac anlagen ([@bib13]), whereas still others, like GATA4, GATA6 ([@bib19], [@bib28]), and various epigenetic enzymes (e.g., p300, histone deacetylases \[HDACs\], and Brg1/Brm-associated factor \[BAF\]) ([@bib5], [@bib21], [@bib37]), coregulate heart development. Although acting with precision, Nkx2.5, Tbx5, and related factors are short-lived and space restricted ([@bib40]), so it is challenging to consider a mechanism that might account for very broad transcriptional regulation within an organ composed of diverse cell types. A baton-like handoff of signals would solve this issue in part, but the nascent cardiac tissue may also require other factors that safeguard the robustness of critical mRNAs that cross developmental boundaries, thereby ensuring the coordination and continuity of transcription.

Ronin (Thap11) is an attractive candidate for such a broad regulatory role in cardiogenesis. Discovered in embryonic stem cells and named after a masterless samurai because of its lack of any apparent relationship to the known "master" regulators of pluripotency, it is essential for this state, both in vitro and in vivo ([@bib7]). Critically, Ronin binds to a hyperconserved promoter sequence (5′-CTGGGARWTGT-3′) present in many genes and spanning various cellular rubrics ([@bib8]). It controls these genes in a yet-undetermined manner in a variety of settings, including the developing eye ([@bib33]), neural crest and craniofacial development ([@bib1]), a cobalamin deficiency syndrome impacting the brain ([@bib2]), hematopoiesis ([@bib18]), cancer cells ([@bib32]), and during the transition from the primed to naive pluripotent stem cell state ([@bib9]). Here, we identify a broad-ranging and dynamic binding pattern that allows Ronin to control gene expression across diverse cell types and temporal hallmarks in the developing heart.

Results {#sec2}
=======

Ronin Displays a Complex and Dynamic Expression Pattern during Embryogenesis {#sec2.1}
----------------------------------------------------------------------------

For a transcriptional regulator to exert broad time- and space-specific control of gene expression across cell types, its expression must be conducive to this function. We therefore tracked Ronin expression during development using *Ronin::lacZ* reporter mice ([Figures 1](#fig1){ref-type="fig"} and [S1](#mmc1){ref-type="supplementary-material"}). Ronin expression underwent a sequence of complex yet spatially well-defined steps as it re-emerged in the mesoderm (E7.0) after an implantational hiatus ([@bib7]), only to be restricted to the cardiac crescent shortly thereafter (E7.5--E8.25) and then to the looped heart tube (E9.0), always bypassing cell-type boundaries. By E9.5, Ronin dominated the endocardial layer of the heart and was strongly expressed in other embryonic structures, such as the thalamus, branchial arches, and posterior neuropore. Ronin expression peaked at E11.5, when lacZ staining was visible throughout larger portions of the heart, most of the nervous system, and many other organs. Histological examination of the heart at this stage showed that Ronin expression was most prominent in the myocardial trabecular layer. This pattern remained essentially unchanged at E13.5, but at the end of trabeculation, Ronin levels had declined and remained detectable in only a small number of cells in the subendocardial layer at P0 (postnatal day 0). String-like subendocardial networks of Ronin-positive cells appeared to persist well into adulthood ([Figures 1](#fig1){ref-type="fig"}D and [S1](#mmc1){ref-type="supplementary-material"}A), whereas histological sections of adult *Ronin::lacZ* hearts betrayed little-to-no Ronin expression in cardiac myocytes ([Figure S1](#mmc1){ref-type="supplementary-material"}B). These observations suggest that Ronin may direct critical genetic programs not only in the preimplantation embryo ([@bib7]), but throughout development and, to a lesser extent, in the adult as well.Figure 1Ronin Is Expressed Early in Cardiogenesis Based on lacZ Expression at the Indicated Developmental Stages(A) At E7.0, Ronin is expressed in the embryonic mesoderm and then appears in the cardiac crescent (E7.5--8.25).(B) It is found in the looped heart tube at E9.0 (left) and the inner layers of the nascent heart structure, the thalamus, branchial arches, and posterior neuropore at E9.5 (middle). Microscopically, hearts at E9.5 (right) show their highest Ronin expression levels in the endocardium and far less in the myocardium.(C) At E11.5, Ronin expression peaks overall (left) and large portions of the heart appear positive (second panel from left). Histologically, the myocardial trabeculae stain positive for Ronin, whereas no signal is seen within the compact layer (right two panels). Note the inward-reaching myocytes (white arrows).(D) The Ronin expression pattern remains essentially unchanged at E13.5, but Ronin expression falls after completion of trabeculation, with only a small ring of Ronin-positive cells (near the subendocardial layers in both ventricles) remaining at P0 and at 8 weeks of age (note that the heart is cut along the midsection).BA, branchial arches; CM, cardiac mesoderm; EC, endocardium; H, heart; LA, left atrium; LHT, looped heart tube; LV, left ventricle; M, mesoderm; MC, myocardium; P, placenta; PNP, posterior neuropore; T, thalamus; V, ventricle. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

Ronin Is Critical for Heart Growth {#sec2.2}
----------------------------------

To gauge the involvement of Ronin in heart development in greater detail, we crossed mice homozygous for the floxed Ronin allele with *Nkx2.5::Cre* animals ([@bib29]) to generate a cardiac progenitor-specific knockout model. The functionality of *Nkx2.5::Cre*-mediated gene ablation was independently confirmed by breeding *Nkx2.5::Cre* mice with *Rosa-26-loxP-STOP* reporter animals ([@bib22]), where we observed red fluorescent protein (RFP)-positive cells in the offspring as early as E7.5 in the cardiac crescent ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Additionally, qRT-PCR analysis confirmed significant reduction of Ronin expression after knockout ([Figure S2](#mmc1){ref-type="supplementary-material"}B). *Nkx2.5::Cre; Ronin*^fl/+^ control embryos lacked any discernible phenotype, whereas most *Nkx2.5::Cre; Ronin*^fl/fl^ embryos died between E11.5 and E13.5 ([Figures 2](#fig2){ref-type="fig"}A and [S2](#mmc1){ref-type="supplementary-material"}C). The E13.5-knockout heart exhibited a proper configuration, including unimpaired endocardial and epicardial linings, but the ventricular walls appeared undernourished and were substantially less dense than those of *Nkx2.5::Cre; Ronin*^fl/+^ control embryos ([Figure 2](#fig2){ref-type="fig"}A, right). This phenotype could reflect the failure of individual cells to grow, a proliferation defect, or perhaps increased apoptosis. To distinguish among these possibilities, we studied knockout hearts at E11.5, observing a decline in the number of proliferating cells, particularly in the trabecular layer of the heart, accompanied by a slight, not statistically significant decrease in apoptosis ([Figure S3](#mmc1){ref-type="supplementary-material"}).Figure 2Early Ablation of *Ronin* Causes Cardiac Defects and Embryonic Lethality(A) After *Nkx2.5*-driven *Ronin* ablation, more than half of the knockout embryos died by E12.5, three-fourths were dead by E13.5, and all embryos died before birth (left, top; n = 49, 59, or 79 at E11.5, E12.5, or E13.5, respectively; p = 2.7 × 10^−6^ by χ^2^ test). Bright-field microscopy of the complete heart (middle) and histological analyses of H&E stained sections (right) revealed much thinner chamber walls in *Nkx2.5*-driven *Ronin* knockout hearts (bottom) than in heterozygous controls at E13.5 (top). Black arrows indicate ultra-thin areas of the myocardium. Comparison of the diameters of the trabecular (Tra) and compacted (Comp) myocardial layers with controls (left, bottom two panels) shows significantly decreased results in both layers of the *Nkx2.5*-driven *Ronin* knockout hearts (^∗^p \< 0.05 by t test). Values are reported as means ± SEM (n = 5 per group).(B) At 8 weeks of age, there are no overt macroscopic differences between hearts isolated from *Tie2*-driven *Ronin* knockout and those of heterozygous control animals (left two panels). Kaplan-Meier survival analysis of *Tie2*-driven *Ronin* knockout animals. None of the animals died postnatally in the first 9 months of life (n = 13, middle panel). H&E staining of tissue sections obtained from knockout animals at 8 weeks of age shows well-ordered alignment of normal cardiomyocytes (right panel).See also [Figures S2--S4](#mmc1){ref-type="supplementary-material"}.

The most parsimonious explanation for our results is that *Ronin* knockout directly triggers a growth defect in cardiac myocytes, leading to altered proliferation and eventually cell death, rather than exerting a direct effect on developmental cell fate decisions. Alternatively, the defect might first emerge in the endocardium and then spread to the heart muscle. This possibility is supported by our previous observation that some endocardial progenitor subsets originate from Nkx2.5-positive cardiogenic mesoderm ([@bib38]). To test for such an initial endocardial defect, we removed *Ronin* from the earliest (E8.25) endocardial cells ([@bib17]) using a *Tie2::Cre*; *Ronin*^fl/fl^ cross ([Figures 2](#fig2){ref-type="fig"}B and [S4](#mmc1){ref-type="supplementary-material"}). Neither embryos nor adult animals resulting from this cross showed any phenotype, arguing against an endocardial origin for the lethality seen in *Nkx2.5::Cre; Ronin*^fl/fl^ embryos. We also considered whether faulty epicardial signaling could be a contributing factor, but this scenario seems unlikely given that only a minute fraction of the epicardial cells expressed Ronin.

Because *Nkx2.5::Cre* removed *Ronin* from the developing heart at a very early time, we next sought to extend our observations to more mature cardiac myocytes using *αMHC (myosin heavy chain)::Cre* as a driver because αMHC is expressed slightly later than Nkx2.5 during embryonic development. Again, we first tested the penetrance of Cre-mediated deletion by crossing the *αMHC::Cre* mice ([@bib3]) with *Rosa-26-loxP-STOP* reporter animals ([@bib22]). Although no Cre activity was detected at E8.0, from E10.5 on, a large proportion of the heart was RFP positive, suggesting *αMHC::Cre*-mediated conditional deletion of *Ronin* as early as E10.5, an effect that is sustained thereafter, as seen in sections at E13.5 or at 5 weeks of age ([Figure S2](#mmc1){ref-type="supplementary-material"}D). When we crossed *Ronin*^*fl/fl*^ animals with *αMHC::Cre* transgenic mice, the loss of *Ronin* did not yield any discernible cardiac growth defect or other abnormality during gestation ([Figure 3](#fig3){ref-type="fig"}A). The pups resulting from this cross were born at normal Mendelian frequencies ([Figure S2](#mmc1){ref-type="supplementary-material"}C) and had apparently normal hearts at birth. However, they became moribund at 3 months of age and none survived beyond 250 days ([Figure 3](#fig3){ref-type="fig"}B). The survival curves of control animals (*αMHC::Cre; Ronin*^fl/+^) mirrored those of age-matched *αMHC::Cre* mice ([Figure S5](#mmc1){ref-type="supplementary-material"}), ruling out Cre toxicity as a cause of the adult phenotype. The sick mice all had dilated cardiomyopathy (DCM) with characteristic echocardiography (ECG) changes, including bradycardia, prolonged QRS intervals, and long QT waves ([Figures 3](#fig3){ref-type="fig"}C--3E). Their left ventricles were dilated, pumped with a low ejection fraction ([Figure 3](#fig3){ref-type="fig"}F), and showed other signs of DCM on echocardiography ([Figure S5](#mmc1){ref-type="supplementary-material"}). Postmortem examination revealed that *αMHC::Cre* mice had enlarged hearts at 12 weeks of age ([Figure 3](#fig3){ref-type="fig"}G). Histologically and ultrastructurally, the heart texture was disordered and featured interstitial fibrosis, nuclear enlargement, G-band streaming, and myocyte degeneration ([Figure 3](#fig3){ref-type="fig"}H). Additionally, we confirmed the elevated expression of known markers of heart failure by RT-PCR ([Figure S7](#mmc1){ref-type="supplementary-material"}A). Thus, *Ronin* knockout by *Nkx2.5* and *αMHC* approaches produced diametrically opposed effects on the developing heart.Figure 3Midgestational Ablation of *Ronin* Leads to Postnatal Dilated Cardiomyopathy in Adult Mice(A) Bright-field photomicrograph shows a normal-looking heart at E13.5 after *αMHC*-driven knockout of *Ronin*.(B) Kaplan-Meier analysis shows that all mice with *αMHC*-driven *Ronin* knockout died before 9 months of age; the mean survival times for control (n = 60) and *Ronin* knockout (n = 62) mice was 262.8 days versus 123.6 days (p = 9.9 × 10^−20^ by log-rank test).(C--E) Determination of heart rate (C) and QRS interval (D) following electrocardiography (E) demonstrate that animals with *αMHC*-driven *Ronin* knockout have bradycardia and a prolonged QRS interval. Bmp; beats per minute.(F) Echocardiography reveals that animals with *Ronin* knockout have a significantly lower ejection fraction, whereas the ventricular end diastolic diameter appears elevated when compared with heterozygous controls. Data are reported as mean ± SEM (n = 5 per group).(G) Neonatal heart size (P0) did not differ between *αMHC*-driven knockout and control animals (top), but at 12 weeks of age, the hearts of knockout animals were clearly enlarged (bottom).(H) H&E staining (top) of heart tissue sections of *αMHC*-driven 6-week-old knockout mice showed hypertrophic cardiomyocytes and lymphocyte infiltration. A more detailed electron microscopic comparison of conditional knockouts with control animals (bottom) revealed fibrosis, increased numbers of mitochondria of various sizes, loss of granules, enlarged, hypertrophic, and disorganized nuclei, and thick Z-bands.See also [Figures S2](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"}.

Ronin Regulates Heart Growth Programs {#sec2.3}
-------------------------------------

The broad though still dynamic expression pattern of Ronin offered a clue as to why the *Nkx2.5*- and *αMHC*-related phenotypes were so different because it suggested that Ronin may modulate a spectrum of vital genes across cell types for only a limited time. To test this hypothesis, we used chromatin immunoprecipitation sequencing (ChIP-seq) analyses of cardiac tissues extracted from E11.5 embryos to map Ronin's target gene repertoire ([Table S1](#mmc2){ref-type="supplementary-material"}). We found that the binding of Ronin overlapped strikingly with that of its cofactor, Hcf-1, underscoring the close relationship between these two proteins ([Figure 4](#fig4){ref-type="fig"}A; [Table S1](#mmc2){ref-type="supplementary-material"}). A DNA motif affiliated with Ronin binding (YGGGNNNYRTAGT; [Figure 4](#fig4){ref-type="fig"}B) was typically located proximal to the transcriptional start sites (p = 1.0 × 10^−15^; [Figure 4](#fig4){ref-type="fig"}C), identical to the Ronin binding signature found in pluripotent stem cells ([@bib8]), retinal progenitors ([@bib33]), and cancer cells ([@bib32]). The genes targeted by Ronin/Hcf-1 largely belonged to metabolism-related categories, including primary metabolism, nucleic acid metabolism, and protein metabolism and transport ([Figure 4](#fig4){ref-type="fig"}D; [Table S1](#mmc2){ref-type="supplementary-material"}). Together, our results suggest that the growth and metabolic pathways controlled by Ronin are indispensable for normal heart development during the E9.5--E11.5 interval and less essential thereafter.Figure 4Ronin Cooperates with Hcf-1 to Regulate Expression of Metabolic Genes during Cardiac Development(A) Venn diagram of ChIP-seq data representing embryonic hearts collected at E11.5. Most of the genes targeted by Ronin are also bound by Hcf-1 and are H3K4me~3~ positive.(B) Consensus sequences of the Ronin binding motif identified after ChIP-seq analysis are almost identical in embryonic heart (top) and embryonic stem cells (bottom).(C) Examples of genes bound by both Ronin and Hcf-1 showing that signals are enriched immediately upstream of transcriptional start sites (arrow).(D) PANTHER analysis classifying GO categories of all Ronin/Hcf-1 target genes assigns the vast majority of Ronin-bound genes to metabolic processes.See also [Table S1](#mmc2){ref-type="supplementary-material"}.

To pursue this hypothesis further and learn if there is a temporal component to the Ronin-mediated regulation of target genes, we scrutinized global gene expression profiles in normal and knockout heart tissues at different time points. The initial gene expression changes were subtle; only around 100 genes were regulated more than 1.5-fold (*Nkx2.5* knockout at E9.5 or *αMHC* knockout at E11.5), with only a few genes exceeding the 2-fold threshold ([Figures 5](#fig5){ref-type="fig"}A--5C and [S6](#mmc1){ref-type="supplementary-material"}; [Table S2](#mmc3){ref-type="supplementary-material"}). These changes translated to more pronounced effects at later developmental stages ([Figures 5](#fig5){ref-type="fig"} and [S7](#mmc1){ref-type="supplementary-material"}). As shown by gene set enrichment analysis (GSEA), a gene signature specific to dilated cardiomyopathy emerged at P0 in *αMHC* knockout hearts and had become significant by 6 weeks ([Figure S7](#mmc1){ref-type="supplementary-material"}B). Gene ontology (GO) analyses revealed that *Ronin* knockout-related gene expression changes were most prominent in metabolic categories at all stages, overlapping with processes involved in organ development (*Nkx2.5* driven) or heart function at later time points (*αMHC* driven; [Figure S6](#mmc1){ref-type="supplementary-material"}; [Table S2](#mmc3){ref-type="supplementary-material"}). The results of our analyses agree with previous findings in the developing retina ([@bib33]), in which *Ronin* knockout led to impaired cell proliferation and increased cell death, most likely due to dysregulation of genes involved in metabolic processes and mitochondrial function in particular. Indeed, the mitochondrial gene signature that was discovered to respond to *Ronin* knockout in the retina was similarly downregulated after *Ronin* knockout in the heart. The affected genes were among the most strongly regulated genes in our experiments ([Figures 5](#fig5){ref-type="fig"}A--5C).Figure 5Ronin and Hcf-1 Cooperate to Regulate Expression of Target Genes during Early Cardiac Development to Control Cardiac Growth(A) Volcano plots of microarray expression data obtained with RNA isolated from control or *Nkx2.5::Cre*-driven *Ronin* knockout heart tissue at the indicated time points. Yellow circles depict members of the mitochondrial gene signature that were discovered to respond to *Ronin* knockout in the retina (expression data with fold changes or p values outside the plot limits are not shown; n = 2 or 3 samples per group for the *αMHC*- or *Nkx2.5*-driven knockout hearts, respectively).(B) Heatmap of mitochondrial genes highlighted in (A).(C) Volcano plots of microarray expression data obtained with RNA isolated from control or *αMHC::Cre*-driven *Ronin* knockout heart tissue at indicated time points (n = 2 per group).(D) GSEA shows that Ronin/Hcf-1 target genes are not significantly regulated between E7.5 and E9.5 (top), whereas significant changes are evident between E9.5 and E11.5 (bottom).(E) Comparison of microarray expression data from control or *Ronin* knockout heart tissue at E11.5 reveals a clear dysregulation of Ronin target genes after *Nkx2.5*-driven knockout (blue line), whereas *αMHC::Cre*-triggered *Ronin* deletion has a less pronounced effect (red line). Fold changes in the expression level of all Ronin/Hcf-1 target genes between knockouts and controls are shown.(F) Sorting of the Ronin/Hcf-1 target genes by expression level in *Nkx2.5*-driven knockout shows that the genes dysregulated in *αMHC*-driven knockout hearts differ from those in *Nkx2.5*-driven knockouts. Fold changes (log2) between knockouts and controls are shown.(G) GSEA reveals that *Nkx2.5*-driven knockout (top) significantly downregulates the expression of Ronin/Hcf-1 targets at E11.5. The heatmap (right) depicts the relative expression levels of the most affected genes. By contrast, *αMHC*-driven knockout (bottom) has no discernible effect on Ronin/Hcf-1 target gene distribution at E11.5. KO, knockout; Ctrl, control.See also [Figures S6--S9](#mmc1){ref-type="supplementary-material"} and [Table S2](#mmc3){ref-type="supplementary-material"}.

Comparison of our molecular findings with the corresponding phenotypes suggested that the *Ronin* knockout-related transcriptional changes during early heart development are highly detrimental, whereas those due to delayed knockout lead to more subtle changes that are tolerated for prolonged times. A clue to the mechanism of these disparate outcomes came from the observation that the expression levels of Ronin target genes fluctuate significantly between E9.5 and E11.5 ([Figure 5](#fig5){ref-type="fig"}D, bottom), but not earlier (between E7.5 to E9.5; [Figure 5](#fig5){ref-type="fig"}D, top). Moreover, the expression of Ronin target genes varied far more after *Nkx2.5*-triggered knockout than after *αMHC* ablation at E11.5 ([Figures 5](#fig5){ref-type="fig"}E, [S7](#mmc1){ref-type="supplementary-material"}C, and S7D; [Table S2](#mmc3){ref-type="supplementary-material"}). Sorting the Ronin/Hcf-1 target genes by expression level after *Nkx2.5* knockout indicated that genes dysregulated after *αMHC* knockout differ from those in *Nkx2.5*-knockout hearts ([Figures 5](#fig5){ref-type="fig"}F and [S7](#mmc1){ref-type="supplementary-material"}E). Additional GSEA ([Figure 5](#fig5){ref-type="fig"}G; [Table S2](#mmc3){ref-type="supplementary-material"}) confirmed these findings. Together, our results show that *Ronin* depletion causes the malfunction of vital developmentally timed genes with a strong bias toward early ontogenic episodes, which helps to explain the attenuated phenotype seen after *αMHC* knockout.

We also examined gene expression changes among markers specific for the myocardial trabecular or compact layer ([@bib20], [@bib23]) in *Ronin* knockout hearts ([Figure S8](#mmc1){ref-type="supplementary-material"}A), but this analysis did not indicate an effect on either layer in particular. It is noteworthy that expression of Bmp10, which is expressed in the trabecular myocardium to sustain proliferation, was slightly elevated, possibly reflecting a compensatory mechanism to counteract the decline in trabecular cardiomyocytes. In addition, the gene expression profile of *Ronin* knockout heart tissue did not indicate a direct disturbance of Notch signaling pathway components, which are intimately involved in the initial formation of the myocardial layers ([Figure S8](#mmc1){ref-type="supplementary-material"}B) early after *Nkx2.5* knockout of *Ronin* at E9.5. Nonetheless, we found that Notch1 and Ronin/Hcf-1 target genes do overlap to some degree. Chip enrichment analysis (ChEA) showed that 32 of our Ronin/Hcf-1 targets are also part of the significantly enriched Notch1 target gene set. Furthermore, a total of 13 Notch1 target genes were regulated more than 1.3-fold in heart tissue at E9.5 after *Nkx2.5* knockout of *Ronin* ([Figures S8](#mmc1){ref-type="supplementary-material"}C and S8D). This suggests that Ronin might act in parallel or downstream of Notch and presumably other canonical signaling pathways to control growth and proliferation.

Additionally, we investigated potential mechanistic links between the transcriptional changes induced by *Ronin* knockout and pathways of cell growth and metabolism in cardiac myocytes. Our PANTHER analyses ([Figure 4](#fig4){ref-type="fig"}D; [Table S1](#mmc2){ref-type="supplementary-material"}) suggested that mTor (mammalian target of rapamycin), a master regulator of cell growth and metabolism ([@bib15], [@bib25]), could contribute to the altered growth phenotype observed in our study. Compelled by additional GSEA results showing dysregulated expression of mTor-related gene signatures as early as E9.5 after *Nkx2.5* knockout ([Figure S9](#mmc1){ref-type="supplementary-material"}A), we examined the effects of *Ronin* ablation on mTor activity. At E11.5, control embryos stained positive for the prototypical target of mTor kinase activity, p-Rps6 (cytoplasmic phosphorylated ribosomal protein S6), but *Nkx2.5::Cre; Ronin*^fl/fl^ embryos showed little p-Rps6 positivity in cardiomyocytes ([Figure S9](#mmc1){ref-type="supplementary-material"}B). Decreased phosphorylation of Rps6 after *Ronin* knockout was confirmed by western blot analysis ([Figure S9](#mmc1){ref-type="supplementary-material"}C), suggesting that Ronin affects mTor signaling in the heart. Hence, the growth defects seen upon early knockout could be a direct consequence of transcriptional influences on mTor pathway components or perhaps a secondary effect of altered amino acid metabolism ([@bib8]).

Ronin Binding Correlates with H3K4me~3~ Levels {#sec2.4}
----------------------------------------------

If, in fact, Ronin controls cell growth and metabolism during heart development, how exactly does it achieve this regulatory end point? Although Ronin lacks a specific transactivation domain, it can act through its coactivator Hcf-1 ([@bib7], [@bib8]), which mobilizes H3K4 methyltransferases with consequent deposition of H3K4me~3~ histone marks ([@bib39]). Such marks could persist at gene loci critical to cardiac growth, thus facilitating rapid cell proliferation during development. To test this hypothesis, we performed ChIP-seq studies on E11.5 control and *Nkx2.5*-driven *Ronin* knockout embryonic heart tissues using antibodies against H3K4me~3~ ([Table S1](#mmc2){ref-type="supplementary-material"}). Strikingly, GO analysis of all gene promoters with significantly lower methylation levels after *Ronin* knockout (*Z* score \> 2) revealed that a number of the associated genes are involved in cardiac function ([Figure 6](#fig6){ref-type="fig"}A; [Table S3](#mmc4){ref-type="supplementary-material"}). When we focused on Ronin/Hcf-1 target genes, we found that most of the downregulated Ronin target genes showed lower levels of H3K4me~3~ compared to (1) genes that were downregulated but not bound by Ronin; or (2) all H3K4me~3~-marked genes ([Figures 6](#fig6){ref-type="fig"}B and 6C; [Table S3](#mmc4){ref-type="supplementary-material"}). *Nkx2.5*-driven Ronin loss significantly reduced the H3K4me~3~ levels at Ronin/Hcf-1 target genes, such as those encoding Apba3 (amyloid beta \[A4\] precursor protein-binding, family A, member 3), Mrpl34 (mitochondrial ribosomal protein L34), Ctf1 (cardiotrophin 1), and Smarcal1 (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1) ([Figure 6](#fig6){ref-type="fig"}D), as confirmed by ChIP-qPCR ([Figure 6](#fig6){ref-type="fig"}E). Interestingly, H3K4me~3~ levels at these genes were less affected overall after *αMHC* knockout. Together, our results are consistent with the hypothesis that Ronin and Hcf-1 are tethered to growth-critical gene promoters, potentially enhancing the number and stability of their H3K4me~3~ marks ([@bib42]). Alternatively, target gene malfunction might be caused by other as-yet-unidentified factors that decrease H3K4me~3~. Thus, *Ronin* knockout may not only cause direct changes in H3K4me~3~ levels and the expression of Ronin/Hcf-1 target genes, but may also affect genes indirectly by triggering the redistribution of additional Hcf-1 moieties to Ronin-independent targets. In this model, an excess of Hcf-1, unable to bind to Ronin target genes after knockout, might accumulate elsewhere in the genome, yielding ectopic H3K4me~3~ deposits. Finally, it is likely that indirect mechanisms not dependent on the presence of Ronin or Hcf-1 are contributing at least in part to the increased H3K4me~3~ levels at gene promoters with negative *Z* scores ([Table S3](#mmc4){ref-type="supplementary-material"}) upon *Ronin* knockout.Figure 6Ronin and Hcf-1 Control Target Genes during Early Cardiac Development by Modulating H3K4 Trimethylation(A) ChIP-seq using H3K4me~3~-specific antibodies and GO analysis of genes with significantly lower H3K4me~3~ status than expected (*Z* score \> 2) *in Nkx2.5::Cre*-driven *Ronin* knockout embryos at E11.5 show significant enrichment of categories related to cardiac function. Depicted are the top categories with fold enrichment scores of \>8.(B) Boxplot (median and interquantile values) of ChIP-seq signal differences comparing H3K4me~3~ levels between *Nkx2.5*-knockout and control hearts at E11.5 (knockout minus control) at promoter regions (TSS to +500 bp) of all H3K4me~3~-marked genes, downregulated Ronin target genes, or downregulated genes that are not bound by Ronin/Hcf-1. The H3K4me~3~ signal of Ronin-regulated target genes is significantly reduced (p \< 0.0002 by t test). TSS, transcriptional start site.(C) The effect of Ronin loss on the spatial distribution of H3K4me~3~ marks in the vicinity of relevant promoters, reported as the average difference in H3K4me~3~ signal between knockout and control, according to the positions of Ronin target genes located ± 1 kb from the TSS. Black line, all H3K4me~3~-marked genes; blue line, downregulated Ronin target genes; red line, all downregulated genes that are not bound by Ronin. Note reduction in H3K4me~3~ upstream of the TSS as well as 200--400 kb downstream of the TSS.(D) Examples of ChIP-seq signals at selected Ronin/Hcf-1 target genes show that the H3K4me~3~ marks at Ronin target genes.(E) ChIP-qPCR using an H3K4me~3~-specific antibody demonstrates that the H3K4me~3~ histone mark is greatly diminished in the promoter region of Ronin target genes in hearts isolated at E11.5 of *Nkx2.5::Cre* and at P0 of *αMHC::Cre* animals after knockout of *Ronin*. The PCR signal after ChIP is shown relative to the signal of the corresponding input sample (^∗^p \< 0.05 by t test, n = 3 per group). Mean ± SEM values are shown.See also [Table S3](#mmc4){ref-type="supplementary-material"}.

Discussion {#sec3}
==========

Over the past two decades, numerous studies have identified most of the diverse progenitor cells that contribute to the proper formation of the developing heart ([@bib34]). However, the molecular cues that orchestrate this process remain under-investigated. Our group and others have shown that embryogenesis imposes stringent metabolic demands that are met not by a homeostatic system of housekeeping genes, but by a precisely regulated gene network, in which Ronin and other factors safeguard biomass assembly and other metabolic needs of embryonic stem cells ([@bib8], [@bib41]).

Here, we asked whether Ronin contributes to mammalian cardiogenesis. Our results suggest that this regulatory factor controls cardiac growth during a critical midgestational period (about E9.5--E11.5), with Hcf-1 binding at active Ronin target genes and consequent changes in H3K4me~3~ levels providing a potential mechanism of action. Support for this hypothesis comes from our observation that Ronin target genes were far more strongly dysregulated and H3K4me~3~ levels at downregulated Ronin target genes more drastically decreased in early *Nkx2.5* knockout mice than in later *αMHC*-driven knockouts ([Figure 6](#fig6){ref-type="fig"}). This model explains both the lethal phenotype seen after the early knockout of *Ronin* and the relatively late onset of the *αMHC*-associated phenotype, which may reflect the slow buildup of pathogenic lesions. Indeed, the gene expression changes after *αMHC* knockout were both moderate and tolerable throughout embryonic development, perhaps because crucial chromatin marks such as H3K4me~3~ are deposited at Ronin target genes before *Ronin* is removed by *αMHC*-Cre. Despite the lack of appreciable Ronin expression in adult cardiac myocytes, we identified persistent string-like subendocardial networks of Ronin-positive cells that might be part of the conductive system of the heart, providing another substrate for the late-onset phenotype. Hence, the postnatal cardiomyopathy and heart failure could be consequences of improper heart development (due to inadequate production, incorrect specification, or elimination of cardiomyocytes) or a later requirement for Ronin in heart function or perhaps a combination of both. Regardless of the mechanism of Ronin action, we recognize that the midgestational period of peak regulatory activity in our model coincides with genome-wide reprogramming of DNA methylation and histone modification in mammalian species ([@bib10]). Because such changes are important for transcriptional gene silencing, they might well have contributed to the results reported here.

Unlike most transcription factors, which bind enhancers, Ronin almost exclusively prefers proximal promoters ([Figure 4](#fig4){ref-type="fig"}C) and lacks a discernible transactivation domain ([@bib8]), suggesting that it has a distinct *modus operandi* for regulating transcription. The available evidence, including data from this study, does not indicate a clear link with any other heart development factor. Instead, studies on the prevalence and conservation of the Ronin binding motif (also known as M4 or LM4) have shown that it stands in striking isolation when compared with similarly conserved sequence elements, much like the CTCF-binding sequence ([@bib43]). Subsequent studies have found that other DNA-binding factors, including ZNF143, GABP, YY1, and ICN1, can recognize part of the Ronin binding sequence, likely in a competitive fashion ([@bib27]), but the exact nature of these interactions is unclear and warrants further study. Finally, it will be interesting to determine whether Ronin's influence on genes involved in cardiogenesis uniformly requires Hcf-1 and methyltransferases or whether other regulatory mechanisms are involved.

Thus, in the developing heart, Ronin controls vital genetic programs across different cell types. This versatile regulatory role seems likely to offer advantages over the action of highly specialized, short-lived transcription factors, such as Nkx2.5 ([@bib40]), in that it can buffer the activity of the short-lived regulators and assist with the transcriptional regulation of critical genes as cells progress through their developmental trajectories. Although the molecular functions of the THAP family proteins (including Ronin) have yet to be fully established, almost all of the characterized THAPs have been implicated in one or more human diseases, including heart disease ([@bib4]), neurodegenerative conditions ([@bib11]), congenital eye defects ([@bib33]), craniofacial abnormalities ([@bib1]), inborn vitamin deficiencies ([@bib35], [@bib2]), and various cancers ([@bib6], [@bib16], [@bib32], [@bib44]). Given the lethal phenotypes observed in our mouse models, we predict that further analyses of human RONIN and its binding partners might reveal novel mutations that could underlie a spectrum of cardiomyopathies and perhaps open the door to new therapeutic strategies ([@bib30]).

Experimental Procedures {#sec4}
=======================

Mice {#sec4.1}
----

All experimental procedures and protocols of animal research were approved by the Institutional Animal Care and Use Committee of Baylor College of Medicine. *Nkx2.5::Cre* mice were provided by Dr. Robert Schwarz ([@bib29]), *Tie2::Cre* mice were provided by Dr. Yanagisawa ([@bib17]), and *Rosa26tdRFP* mice were provided by Dr. Fehling ([@bib22]). *αMHC::Cre*, *Ronin::lacZ*, and *Ronin*^*fl/fl*^ mice were maintained as previously described ([@bib3], [@bib7], [@bib8]). To create cardiac-specific Ronin conditional knockout animals, *Ronin*^*fl/fl*^ mice were crossed with mice expressing the Cre recombinase under the control of a cardio-myocyte-specific promoter (*αMHC::Cre*, *Nkx2.5::Cre*, or *Tie2::Cre*) and backcrossed with *Ronin*^*fl/fl*^ mice.

Tissue ChIP {#sec4.2}
-----------

Heart tissue from E11.5 embryos (at least 12 hearts pooled per group per sample) or P0 neonates (3 hearts pooled per group per sample) were collected and snap frozen in liquid nitrogen. After thawing, DNA and protein were crosslinked in 1% (v/v) formaldehyde-PBS for 15 min. The crosslinking reaction was quenched by the addition of glycine to a final concentration of 0.125 M and incubation for a further 5 min. All tissues were rinsed in cold PBS containing protease inhibitors (Roche) and PMSF before they were resuspended in 1 mL cold cell lysis buffer (10 mM Tris-HCl \[pH 7.5\], 10 mM NaCl, 3 mM MgCl~2~, and 0.5% \[v/v\] NP-40) containing protease inhibitors and PMSF. The tissue was homogenized with a 2-mL dounce homogenizer and incubated on ice for 10 min to allow the release of nuclei. Nuclei were then collected by centrifugation at 3,000 rpm for 5 min, and each pellet was resuspended in cell lysis buffer and incubated for 5 min at 4°C with rotation. This step was repeated, followed by sonication (five times) with a Sonic dismembrator (Model 100, Fisher Scientific) for 6 s using a microtip probe (power output of 6). The tissues were next incubated with micrococcal nuclease (LS004798, Worthington Biochemical; 60 U/mL or 150 U/mL of E11.5 or P0 heart tissue, respectively). Insoluble debris was removed by centrifugation at 13,000 rpm for 10 min at 4°C, and supernatants were transferred to fresh reaction tubes. The extent of chromatin shearing was evaluated via 1.5% (w/v) agarose gel electrophoresis. The chromatin was precleared by the addition of 4 μL rabbit immunoglobulin G (IgG) or 6 μL preimmune serum and rotation for 1 hr at 4°C. 6 μL Ronin antiserum (G4275; [@bib7]), 12 μL anti-Hcf-1 antibody (A301-400A, Bethyl), or 5 μL anti-trimethylated H3K4me~3~ antibody (39159, Active Motif) were added to the supernatants, and samples were rotated overnight at 4°C. Salmon sperm DNA was added to a final concentration of 0.25 mg/mL, followed by incubation (with rotation) for 1 hr at 4°C. 50% Protein-A Sepharose (pre-treated by rotation with salmon sperm DNA at a final concentration of 0.25 mg/mL for 1 hr) was added to the samples, followed by incubation for 3 hr at 4°C, rotating. After four successive washes with 500 μL low-salt wash buffer (0.05% \[w/v\] SDS, 1% \[v/v\] Triton X-100, 2 mM EDTA, 20 mM Tris-HCl \[pH 7.5\], and 150 mM NaCl, with proteinase inhibitors), a high-salt wash buffer (0.05% \[w/v\] SDS, 1% \[v/v\] Triton X-100, 2 mM EDTA, 20 mM Tris-HCl \[pH 7.5\], and 500 mM NaCl, with proteinase inhibitors), LiCl wash buffer (0.25 M LiCl, 1% \[v/v\] NP-40, 1% \[w/v\] Na deoxycholate, 1 mM EDTA, and 10 mM Tris-HCl \[pH 7.5\], with proteinase inhibitors), and wash buffer (1% \[v/v\] Triton X-100, 2 mM EDTA, 20 mM Tris-HCl \[pH 7.5\], and 500 mM NaCl, with proteinase inhibitors), the Sepharose was resuspended in 300 μL Tris EDTA (TE) supplemented with 30 mM NaCl. Crosslinking was reversed by overnight incubation at 65° C, and the DNA was extracted twice with phenol/chloroform, precipitated with ethanol and resuspended in H~2~O.

Microarray Analysis of Heart-Specific Ronin Conditional Knockout Mice {#sec4.3}
---------------------------------------------------------------------

Hearts were isolated at E9.5 (10 hearts were pooled per group per replicate), E11.5, P0, or 6 weeks of age. RNA was isolated with the RNeasy kit (QIAGEN) following the manufacturer's standard protocol for isolation of RNA from animal tissue, including the on-column DNA digest. The microarray (MouseWG-6 v. 2.0 Illumina) was performed at the Microarray Core at Texas Children's Hospital. The resultant data were either normalized by quantile normalization ([Figures 5](#fig5){ref-type="fig"}D--5G; [Table S2](#mmc3){ref-type="supplementary-material"}) with the Bioconductor package ([@bib12]) or cubic spline normalization was performed with the Genepattern modules for Illumina expression file creation and normalization (Broad Institute). The E7.5 and E9.5 microarray datasets for the GSEA analysis shown in [Figure 5](#fig5){ref-type="fig"}D (top) were reconstructed from [@bib26].

Immunofluorescence {#sec4.4}
------------------

Embryos were fixed in 4% (v/v) paraformaldehyde at 4°C. Cryostat sections (8 μm each) were stained overnight at 4°C using specific antibodies diluted in PBS (anti-phospho-S6 ribosomal protein antibody \[2211, Cell Signaling Technology, 1:200\]), anti-RFP antibody (M155-3, MBL; 1:2,000), anti-α-Actinin antibody (A17811, Sigma; 1:400), or anti-phospho-H3 (Ser10) (06-570, Millipore; 1:100). Sections were washed three times with PBS, followed by incubation with the secondary antibodies conjugated to Alexa Fluor 488 or 594 (Invitrogen; 1:1,000). The sections were mounted with Vectashield mounting medium containing DAPI (Vector Laboratories) to visualize the nuclei. Slides were analyzed with an Axiocam 2 microscope (Carl Zeiss, Jena, Germany). Quantification after phospho-H3 (Ser10) staining was done with the ImageJ software. Five animals were analyzed per group. At least 3,600 myocardial (α-Actinin and DAPI positive) cells were counted per layer in each group.
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Data and Software Availability {#app1}
==============================

The accession number for the microarray data reported in this paper is GEO: [GSE103959](ncbi-geo:GSE103959){#intref0010} (<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE103959>).
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Document S1. Supplemental Experimental Procedures and Figures S1--S9Table S1. PANTHER Analysis of Ronin/Hcf-1-Bound Genes in Embryonic Heart Tissue at E11.5Table S2. GSEA Analysis of Ronin/Hcf-1 Targets in Control versus Nkx2.5-Driven Ronin Knockout Heart Tissue at E11.5Shown are the Ronin/Hcf-1 targets ranked by their enrichment in expression level in controls versus knockout heart tissue. The heat map in Figure 5G includes the top 50 genes enriched in control hearts. ES, enrichment score.Table S3. Comparison of H3K4me3 Status in Heart Tissue of Controls or Nkx2.5::Cre-Driven Ronin Knockout Embryos at E11.5Shown is the linear regression of the H3K4me3 raw signal at all gene promoters in knockout tissue as a function of the signal in controls. Positive *Z* scores indicate promoters with lower H3K4me3 levels; negative *Z* scores indicate promoters with higher H3K4me3 levels in Ronin knockout tissue when compared with controls. Slope = 0.74; Intercept: 0.01. Chr, chromosome.Document S2. Article plus Supplemental Information
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